Next-Generation Microfluidic Technology for Gene-Editing in Human Primary T Cells Using CRISPR-Cas9

被引：0
|
作者：
Goff, Ailin M. [1 ]
Bourke, Struan [1 ]
Kim, Ockchul [1 ]
Sicher, Ian [1 ]
Alexeev, Alexander [1 ]
Sulchek, Todd [1 ]
Zamarevya, Alla [1 ]
Han, Sewoon [1 ]
Ni, Chih-Wen [1 ]
机构：
[1] CellFE, Alameda, CA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1224
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [1] Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
    Alexander Dimitri
    Friederike Herbst
    Joseph A. Fraietta
    Molecular Cancer, 21
  • [2] Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
    Dimitri, Alexander
    Herbst, Friederike
    Fraietta, Joseph A.
    MOLECULAR CANCER, 2022, 21 (01)
  • [3] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Ziyi Zhao
    Chenxi Li
    Fei Tong
    Jingkuang Deng
    Guofu Huang
    Yi Sang
    Biological Procedures Online, 23
  • [4] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Zhao, Ziyi
    Li, Chenxi
    Tong, Fei
    Deng, Jingkuang
    Huang, Guofu
    Sang, Yi
    BIOLOGICAL PROCEDURES ONLINE, 2021, 23 (01)
  • [5] Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?
    Ahmadi, Fatemeh
    Quach, Angela B. V.
    Shih, Steve C. C.
    BIOMICROFLUIDICS, 2020, 14 (06)
  • [6] Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy
    Afolabi, Lukman O.
    Afolabi, Mariam O.
    Sani, Musbahu M.
    Okunowo, Wahab O.
    Yan, Dehong
    Chen, Liang
    Zhang, Yaou
    Wan, Xiaochun
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (06)
  • [7] CRISPR-CAS9 RNP EDITING OF PRIMARY T CELLS USING THE FLOWFECT® TRANSFECTION TECHNOLOGY PLATFORM
    Zhao, J.
    Lewis, G.
    Baladiang, M.
    Hallinan, A.
    Sido, J.
    Beighley, R.
    Latouche, E.
    Hang, T.
    Grant, B.
    Buie, C.
    Garcia, P. A.
    CYTOTHERAPY, 2022, 24 (05) : S132 - S132
  • [8] CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform
    Lewis, Gretchen
    Zhao, John
    Baladiang, Michael
    Hallinan, Andrew
    Sido, Jessica
    Beighley, Ross
    Latouche, Eduardo
    Hang, Ta-Chun
    Grant, Bethany
    Buie, Cullen R.
    Garcia, Paulo A.
    MOLECULAR THERAPY, 2022, 30 (04) : 543 - 544
  • [9] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204
  • [10] Next-generation gene-editing platforms drive CRISPR deals
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 170 - 170
12345